163 related articles for article (PubMed ID: 2439837)
1. Prejunctional alpha-adrenoceptor-mediated inhibition of norepinephrine release in blood-perfused skeletal muscle in situ.
Kahan T; Dahlöf C; Hjemdahl P
J Cardiovasc Pharmacol; 1987 May; 9(5):555-62. PubMed ID: 2439837
[TBL] [Abstract][Full Text] [Related]
2. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
Kahan T
Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
4. Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo.
Kahan T; Pernow J; Schwieler J; Wallin BG; Lundberg JM; Hjemdahl P
Br J Pharmacol; 1988 Dec; 95(4):1101-8. PubMed ID: 2851357
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postjunctional alpha-adrenoceptor-mediated effects of prazosin, methoxamine and 6-fluoronoradrenaline in blood-perfused canine skeletal muscle in situ.
Kahan T; Hjemdahl P
Eur J Pharmacol; 1987 Jan; 133(1):9-20. PubMed ID: 3030774
[TBL] [Abstract][Full Text] [Related]
6. Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo.
Schwieler JH; Kahan T; Nussberger J; Johansson MC; Hjemdahl P
Acta Physiol Scand; 1992 Aug; 145(4):333-43. PubMed ID: 1326853
[TBL] [Abstract][Full Text] [Related]
7. Prejunctional beta 2-adrenoceptor-mediated enhancement of noradrenaline release in skeletal muscle vasculature in situ.
Kahan T; Hjemdahl P
J Cardiovasc Pharmacol; 1987 Oct; 10(4):433-8. PubMed ID: 2444796
[TBL] [Abstract][Full Text] [Related]
8. Prejunctional beta 2-adrenoreceptor blockade reduces nerve stimulation evoked release of endogenous noradrenaline in skeletal muscle in situ.
Dahlöf C; Kahan T; Ablad B
Acta Physiol Scand; 1987 Apr; 129(4):499-503. PubMed ID: 2884805
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of resistance to alpha-adrenergic receptor antagonists of renal nerve stimulation-induced vasoconstriction at low frequencies.
Sehic E; Ruan Y; Malik KU
J Cardiovasc Pharmacol; 1997 Jan; 29(1):97-108. PubMed ID: 9007678
[TBL] [Abstract][Full Text] [Related]
10. Transmitter release modulated by alpha-adrenoceptor antagonists in the rabbit mesenteric artery: a comparison between noradrenaline outflow and electrical activity.
Mishima S; Miyahara H; Suzuki H
Br J Pharmacol; 1984 Oct; 83(2):537-47. PubMed ID: 6148987
[TBL] [Abstract][Full Text] [Related]
11. Modulatory role of alpha adrenoceptors on the release of [3H]norepinephrine elicited by preganglionic stimulation of the cat superior cervical ganglion.
Martínez AE; Adler-Graschinsky E
J Pharmacol Exp Ther; 1980 Mar; 212(3):533-5. PubMed ID: 6102146
[TBL] [Abstract][Full Text] [Related]
12. An attempt at selective protection from phenoxybenzamine of postjunctional alpha-adrenoceptor subtypes mediating contractions to noradrenaline in the rabbit isolated saphenous vein.
Daly CJ; Dunn WR; McGrath JC; Wilson VG
Br J Pharmacol; 1988 Oct; 95(2):501-11. PubMed ID: 2906558
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle.
Kahan T; Hjemdahl P; Dahlöf C
Acta Physiol Scand; 1984 Dec; 122(4):571-82. PubMed ID: 6098140
[TBL] [Abstract][Full Text] [Related]
14. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture.
Hill CE; Powis DA; Hendry IA
Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104
[TBL] [Abstract][Full Text] [Related]
15. Prejunctional alpha 2-adrenoceptors modulate stimulation-evoked norepinephrine release in rabbit lateral saphenous vein.
Levitt B; Hieble JP
Eur J Pharmacol; 1986 Dec; 132(2-3):197-205. PubMed ID: 2880733
[TBL] [Abstract][Full Text] [Related]
16. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
[TBL] [Abstract][Full Text] [Related]
17. Sympathetic control of nasal blood flow in the rat mediated by alpha(1)-adrenoceptors.
Kawarai M; Koss MC
Eur J Pharmacol; 2001 Feb; 413(2-3):255-62. PubMed ID: 11226401
[TBL] [Abstract][Full Text] [Related]
18. Evidence for prejunctional alpha- and beta-adrenoceptors in the canine saphenous vein: influence of frequency of stimulation and external calcium concentration.
Saelens DA; Williams PB
J Cardiovasc Pharmacol; 1983; 5(4):598-603. PubMed ID: 6193357
[TBL] [Abstract][Full Text] [Related]
19. Nerve stimulation-meditated overflow of norepinephrine and dopamine-beta-hydroxylase. III. Effects of norepinephrine depletion on the alpha presynaptic regulation of release.
Cubeddu L; Weiner N
J Pharmacol Exp Ther; 1975 Jan; 192(1):1-14. PubMed ID: 235629
[TBL] [Abstract][Full Text] [Related]
20. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
